Manigittis exam based shor note answer

I'll look up meningitis for a concise exam-focused short note. Let me check the medical library skill first.
Reading File
Now let me search the medical library for meningitis content in parallel:
Finding Sources
Finding Sources
Good. Let me now pull the detailed content from the best neurology and emergency medicine sources in parallel:
Reading File
Reading File
Reading File
Excellent content. Let me now pull the CSF findings and management sections:
Reading File
Finding Sources
Reading File
Finding Sources
Let me now get the Harrison's meningitis section and CSF findings table for the most exam-relevant content:
Reading File
Finding Sources
Reading File
Reading File
I now have comprehensive, exam-quality content from Harrison's and Tintinalli's. Let me compose the full short note answer.

MENINGITIS - Exam Short Note

Definition

Meningitis is inflammation of the meninges (pia, arachnoid, and dura mater) and the subarachnoid CSF, caused by infectious or non-infectious agents.

Classification

TypeCommon Causes
Acute BacterialS. pneumoniae, N. meningitidis, H. influenzae type b, Group B Streptococcus (neonates), L. monocytogenes
Viral (Aseptic)Enteroviruses (echovirus, Coxsackie - 80%), HSV-2, HIV, mumps, VZV
Subacute/ChronicM. tuberculosis (most common chronic cause), Cryptococcus neoformans, fungal species
NeonatalGroup B Streptococcus, E. coli, L. monocytogenes
Age-specific organisms:
  • <1 month: GBS, E. coli, Listeria
  • 1 month - 50 years: N. meningitidis, S. pneumoniae
  • >50 years / immunocompromised: S. pneumoniae, gram-negative rods, Listeria
  • Post-neurosurgical / shunt: S. aureus, coagulase-negative staphylococci

Pathophysiology

  1. Nasopharyngeal colonization by bacteria (e.g., S. pneumoniae, N. meningitidis)
  2. Invasion across epithelial tight junctions into bloodstream
  3. Bacteria survive via polysaccharide capsule (resist phagocytosis + complement)
  4. Reach choroid plexus → enter CSF
  5. Rapid multiplication in CSF (poor complement/IgG levels - normal CSF has few WBCs)
  6. Bacterial cell wall components trigger cytokine-mediated inflammatory response
  7. Increased vascular permeability → cerebral edema → raised ICP → tissue damage
(Source: Harrison's Principles of Internal Medicine 22E, p. 1163-1164)

Clinical Features

Classic Triad:

Fever + Headache + Neck stiffness (nuchal rigidity)

Additional features:

  • Photophobia, phonophobia
  • Nausea, vomiting
  • Altered consciousness / confusion
  • Seizures
  • Petechial/purpuric rash (classic for N. meningitidis)

Meningeal Signs:

  • Kernig's sign - Patient supine; flex thigh on abdomen + flex knee; passive extension of knee causes pain/resistance
  • Brudzinski's sign - Passive neck flexion causes involuntary flexion of hips and knees
  • Bulging fontanelle (in neonates/infants)

Neonatal presentation (non-specific):

Lethargy, poor feeding, hypothermia or fever, bulging fontanelle, grunting, respiratory distress, seizures

Diagnosis

Lumbar Puncture - CSF Analysis (KEY EXAM TABLE)

ParameterNormalBacterialViralTB/Fungal
AppearanceClearTurbid/cloudyClearOpalescent
Opening pressure<180 mmH₂ORaised (>180)Normal/mildly raisedRaised
WBC count<5 cells/μL>100 (PMN predominance)10-500 (lymphocyte predominance)10-500 (lymphocyte predominance)
Glucose50-80 mg/dL (CSF:serum >0.6)LOW (<40 mg/dL; CSF:serum <0.4)NormalLOW
Protein15-45 mg/dLHIGH (>45 mg/dL; often >100)Mildly elevatedHIGH
Gram stainNegativePositive in >60%NegativeAFB stain
CultureNegativePositive >70%Viral cultureCulture / PCR
From Harrison's: Classic CSF abnormalities in bacterial meningitis: (1) PMN leukocytosis >100 cells/μL in 90%, (2) glucose <40 mg/dL and/or CSF:serum ratio <0.4 in ~60%, (3) protein >45 mg/dL in 90%, (4) opening pressure >180 mmH₂O in 90%.

When to CT BEFORE LP:

  • Focal neurologic deficits
  • Papilledema
  • Impaired consciousness
  • History of recent head trauma / immunocompromised
  • (Do NOT delay antibiotics for imaging)

Bacterial Meningitis Score (BMS) - pediatric:

  • CSF Gram stain positive (2 points)
  • CSF protein >80 mg/dL (1 point)
  • Blood absolute neutrophil count ≥10,000/mm³ (1 point)
  • Seizure at or before presentation (1 point)
  • CSF WBC ≥100 cells/μL (1 point)

Treatment

Empirical Antimicrobial Therapy (community-acquired, adults/older children):

Regimen ComponentDrug
3rd/4th gen cephalosporinCeftriaxone 2g IV q12h OR Cefotaxime
For resistant S. pneumoniae+ Vancomycin
Cover Listeria (if <3 months, >55 yrs, immunocompromised, pregnancy)+ Ampicillin
HSV encephalitis in differential+ Acyclovir
Anaerobes (otitis/sinusitis/mastoiditis)+ Metronidazole
Hospital-acquired / post-neurosurgicalVancomycin + Cefotaxime or Meropenem
Goal: antibiotics within 60 minutes of emergency room arrival (Harrison's 22E, p. 1164)

Adjunctive Dexamethasone:

  • 0.15 mg/kg IV every 6 hours for 4 days (up to 10 mg per dose)
  • Give before or with the first antibiotic dose (ideally 20 minutes before)
  • Reduces mortality in pneumococcal meningitis
  • Reduces hearing loss (especially in H. influenzae meningitis)
  • Mechanism: reduces CNS inflammation and cytokine storm

Neonatal empirical therapy:

  • Ampicillin + Cefotaxime (or Gentamicin) - covers GBS, E. coli, Listeria

Complications

  • Sensorineural hearing loss (most common neurologic sequela; predicted by S. pneumoniae etiology and low CSF glucose)
  • Hydrocephalus
  • Cerebral edema / raised ICP
  • Seizures
  • Waterhouse-Friderichsen syndrome (bilateral adrenal hemorrhage in meningococcemia)
  • Subdural effusion / empyema
  • Cognitive impairment, learning disabilities
  • Death - mortality <10% with appropriate antibiotics
Predictors of mortality: coma, seizures, shock, respiratory distress, neutropenia, high CSF protein

Prevention

  • Hib vaccine (dramatically reduced H. influenzae meningitis in children)
  • Pneumococcal vaccine (PCV13 / PPSV23)
  • Tetravalent meningococcal vaccine (serogroups A, C, W-135, Y)
  • MenB vaccine (serogroup B, now required for many university students)

Sources: Harrison's Principles of Internal Medicine 22E, p. 1163-1165 | Tintinalli's Emergency Medicine, p. 795 | Bradley and Daroff's Neurology in Clinical Practice, p. 1698
This is a shared conversation. Sign in to Orris to start your own chat.